Rochester-based OptimizeRx Corp. (Pink Sheets: OPRX) this week announced it had completed a $3.5 million financing transaction to support its growth plans for www.optimizerx.com and to accelerate the rollout of its marketing platforms.
The $3.5 mllion was structured as preferred shares that are convertible into common shares. The unnamed investor also received warrants in the deal. The financing was placed by Midtown Partners & Co. LLC, a Tampa, Fla.-based securities broker-dealer.
OptimizeRx.com provides patients a central means to access and enroll in more than 150 savings and support programs from leading prescription brands. In turn, OptimizeRx provides pharmaceutical and healthcare brands unique advertising that directly engages motivated health consumers looking for their type of products and support.
OffeRx provides a single, turn-key platform to allow more pharmaceutical and health care companies to develop, test and expand superior patient savings and support programs on a faster and more cost-effective basis.
The company's upcoming launch of Adherxe will also provide turn-key systems to address the pharmaceutical industry's number one challenge: helping patients stay on their medicines longer.
The Adherxe platform will soon allow leading prescription brands to turn their patient offers into powerful compliance programs that include surveying patient results each month in exchange for re-activation of their co-pay card. This program allows the brand to regularly engage the patient and helps minimize any barriers on maintaining treatments for important chronic therapies.
E-Mail Story
Print Story
